Showing results (1-10 of 1,145) with videos related to
Sort By:
Pageof 115
Diabetologia|April 12, 2008
Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategyR Simó, C HernándezDiabetic Medicine : a Journal of the British Diabetic Association|December 21, 2004
Soluble transferrin receptors and ferritin in Type 2 diabetic patientsC Hernández, A Lecube, A Carrera, et al.International Journal of Obesity (2005)|September 10, 2008
Factors accounting for high ferritin levels in obesityA Lecube, C Hernández, D Pelegrí, et al.Diabetes Care|February 24, 2001
Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patientsC Hernández, P Chacón, L García-Pascual, et al.Journal of Endocrinological Investigation|March 31, 2017
Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanismsC Hernández, A Simó-Servat, P Bogdanov, et al.Diabetes Care|September 1, 1996
High prevalence of hepatitis C virus infection in diabetic patientsR Simó, C Hernández, J Genescà, et al.Medicina Clinica|August 23, 2000
[Relationship between iron stores and diabetes mellitus in patients infected by hepatitis C virus: a case-control study]C Hernández, J Genescà, J Ignasi Esteban, et al.Diabetologia|March 4, 2011
Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activationM Villarroel, M Garcia-Ramírez, L Corraliza, et al.Medicina Clinica|December 22, 1999
[Lipoprotein (a) and the evaluation of low density cholesterol by the Friedewald formula: a new problem for an old equation]C Hernández, P Chacón, L García-Pascual, et al.Thrombosis Research|August 18, 2000
Relationship between lipoprotein(a) phenotypes and plaminogen activator inhibitor type 1 in diabetic patientsC Hernández, P Chacón, L García-Pascual, et al.Pageof 115